EUVIMED · CrossrefJournal
Drug Metabolism and Disposition
ISSN 0090-9556 · Elsevier BV
Latest articles
Cyclical heat strain alters the function of hepatic cytochrome P450 enzymes in rats
Species differences in loxoprofen reductase activities: Roles of aldo-keto and carbonyl reductases in humans and rats
Corrigendum to “Clopidogrel–indobufen conjugates as dual antiplatelet prodrugs with enhanced bioactivation and synchronized pharmacokinetic–pharmacodynamic profiles in rats” [Drug Metabolism and Disposition 54 (2026) 100212]
A previously undetected major circulating metabolite of trazpiroben revealed by human radiolabeled absorption, distribution, metabolism, and excretion study
Multidimensional regulation of the cytochrome P450 metabolic network in pulmonary arterial hypertension: Homeostatic imbalance, pathological drivers, and environmental interactions
Absorption, distribution, metabolism, excretion, and pharmacokinetics of remibrutinib, an oral, highly selective Bruton tyrosine kinase inhibitor, in healthy participants at steady state
Review of the selectivity of chlorzoxazone 6-hydroxylation as a probe for human cytochrome P450 2E1
Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin
Absorption, distribution, metabolism, and excretion of the BMS-986365 ligand-directed degrader diastereomers, R,R-[14C]BMS-986409 and R,S-[14C]BMS-986410, following oral administration in combination with an intravenous microtracer in healthy male participants
Investigation of the Nonlinear Pharmacokinetics of Vismodegib in Humans: Using PBPK Modeling to Examine Contributions of Saturable Plasma Protein Binding and Nonsink Permeation
Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing
Quantitative determination of lysosomal accumulation fraction, flyso, for estimating Kp,uu,brain tumor and target coverage for drugs treating human glioblastoma
Systematic search on fat free mass and fat mass in exclusively breastfed infants until one year of age – a contribution from the ConcePTION project
Discovery, Evolution, and Applications of Mass Defect Filtering in Drug Metabolite Identification
Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota
A novel in vitro permeability and efflux classification system for proteolysis targeting chimeras
A herb–drug interaction: The role of transporters in the modulation of atorvastatin absorption by Compound Danshen Tablets
Systemic inflammation reprograms human hepatic phenotype and suppresses absorption, distribution, metabolism, and excretion gene expression: Validation in a 3-dimensional human liver spheroid system
Proteomic characterization of human kinases across tissue types: Implications for kinase-activated drugs
Integrated assessment of cytochrome P450 inhibition by açaí and mass spectrometry–based identification of P450 inhibitory constituents using biochemometric approaches
The absorption, distribution, metabolism, excretion, and pharmacokinetic properties of the pan–rapidly accelerated fibrosarcoma (RAF) inhibitor naporafenib in healthy subjects: An absolute bioavailability and mass balance study
Liquid chromatography–high-resolution mass spectrometry–based integrated strategy combining in silico prediction and molecular networking for metabolite identification of podophyllotoxin in a fatal poisoning case
Role of CYP3A4 in the metabolism of tyrosine kinase inhibitors in non–small cell lung cancer therapy
Inhibition of cytochrome P450 2B6 activity by kava extracts
From systemic circulation to male gametes: Comparative pharmacokinetics of ivermectin in plasma, seminal plasma, and spermatozoa of Awassi rams
Idelalisib 8-oxidation as an enzyme-selective catalytic marker of human aldehyde oxidase in HepG2 cells: Application to the investigation of enzyme inactivation
Submicellar aggregates of deoxycholate and glycodeoxycholate suppress in vitro CYP3A oxidation via membrane perturbation
Repaglinide metabolism by human hepatocytes reveals CYP2C8 dominance and misassignment of CYP3A4 by liver subcellular fractions and recombinant enzymes
Interindividual variability in hepatic hydrolytic enzymes: Effects of age, sex, and race on the abundance of drug-metabolizing hydrolases
Soluble epoxide hydrolase research, international collaboration, and translational capacity in Brazil: the scientific legacy of Bruce D. Hammock
Volumes
2026 · 2282025 · 1962024 · 1752023 · 1922022 · 1742021 · 1252020 · 1682019 · 1732018 · 2312017 · 1842016 · 2552015 · 2562014 · 2762013 · 2782012 · 3122011 · 3282010 · 3442009 · 3502008 · 3682007 · 3562006 · 3322005 · 2882004 · 2452003 · 2412002 · 2542001 · 252000 · 2571999 · 2521998 · 381997 · 401996 · 2551995 · 2731994 · 1761993 · 2051992 · 1811991 · 2041990 · 1941989 · 1261988 · 1641987 · 157
EUVIMED